Breast and Colorectal Cancer Screening Rates Surge in 2023

In a promising turn of events, reported rates of breast and colorectal cancer screenings have shown significant improvement in 2023, surpassing figures from before the COVID-19 pandemic. A research letter released on March 5 in the Journal of the American Medical Association highlights these encouraging trends, with data revealing a rebound from the declines witnessed in the previous years.

Led by Jessica Star, M.P.H., from the American Cancer Society in Atlanta, the study utilized data collected from the National Health Interview Survey. This comprehensive exercise assessed the post-pandemic cancer screening landscape in 2023, illustrating how critical the recovery has been after the sharp drops reported through 2021.

The findings are striking—out of a total of 6,829 individuals eligible for breast cancer screening, 8,888 for cervical screenings, and a notable 13,144 for colorectal screenings, reported rates increased by 7% for breast cancer screening and 12% for colorectal screening when comparing 2023 figures to those of 2019. This remarkable resurgence can be attributed specifically to a rebound in both breast cancer screenings and colonoscopy procedures, as well as a sustained rise in stool testing—from 6.6% in 2019 to a steady 10.1% in both 2021 and 2023.

However, it's worth noting that cervical cancer screening has not fared as well. The reported rates in 2023 were still below those of 2019, with no changes since 2021, identified as problematic by the authors. "To prevent further shifts toward later-stage diagnoses, efforts must address declines in cervical cancer screening and disparities by socioeconomic status in all three screening types," they emphasized.

To tackle these challenges, it is crucial for health systems and professionals to enhance communication regarding screening processes and offer navigators to patients. These efforts could help clear the structural and financial barriers that hinder individuals from accessing essential health services, especially among disadvantaged groups.

This push for improved screening not only aims to catch cancers earlier but also serves as a pivotal step toward reducing health disparities within our communities. With continued focus and dedication, the health sector can make significant strides in combatting cancer and supporting affected individuals.